1. Microbiology and Infectious Disease

Dynamic post-translational modification profiling of M. tuberculosis-infected primary macrophages

  1. Jonathan M Budzik
  2. Danielle L Swaney
  3. David Jimenez-Morales
  4. Jeffrey R Johnson
  5. Nicholas E Garelis
  6. Teresa Repasy
  7. Allison W Roberts
  8. Lauren M Popov
  9. Trevor J Parry
  10. Dexter Pratt
  11. Trey Ideker
  12. Nevan J Krogan
  13. Jeffery S Cox  Is a corresponding author
  1. University of California, San Francisco, United States
  2. University of California, Berkeley, United States
  3. University of California, San Diego, United States
https://doi.org/10.7554/eLife.51461
Share this article
Cite this article
  1. Jonathan M Budzik
  2. Danielle L Swaney
  3. David Jimenez-Morales
  4. Jeffrey R Johnson
  5. Nicholas E Garelis
  6. Teresa Repasy
  7. Allison W Roberts
  8. Lauren M Popov
  9. Trevor J Parry
  10. Dexter Pratt
  11. Trey Ideker
  12. Nevan J Krogan
  13. Jeffery S Cox
(2020)
Dynamic post-translational modification profiling of M. tuberculosis-infected primary macrophages
eLife 9:e51461.
https://doi.org/10.7554/eLife.51461
  2. Download BibTeX
  3. Download .RIS

Abstract

Macrophages are highly plastic cells with critical roles in immunity, cancer, and tissue homeostasis, but how these distinct cellular fates are triggered by environmental cues is poorly understood. To uncover how primary murine macrophages respond to bacterial pathogens, we globally assessed changes in post-translational modifications of proteins during infection with Mycobacterium tuberculosis, a notorious intracellular pathogen. We identified hundreds of dynamically regulated phosphorylation and ubiquitylation sites, indicating that dramatic remodeling of multiple host pathways, both expected and unexpected, occurred during infection. Most of these cellular changes were not captured by mRNA profiling, and included activation of ubiquitin-mediated autophagy, an evolutionarily ancient cellular antimicrobial system. This analysis also revealed that a particular autophagy receptor, TAX1BP1, mediates clearance of ubiquitylated Mtb and targets bacteria to LC3-positive phagophores. These studies provide a new resource for understanding how macrophages shape their proteome to meet the challenge of infection.

Data availability

The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD015361.

The following data sets were generated

Article and author information

Author details

  1. Jonathan M Budzik

    Department of Medicine, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.

  2. Danielle L Swaney

    Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6119-6084

  3. David Jimenez-Morales

    Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.

  4. Jeffrey R Johnson

    Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francsico, United States
    Competing interests
    The authors declare that no competing interests exist.

  5. Nicholas E Garelis

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.

  6. Teresa Repasy

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.

  7. Allison W Roberts

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6681-4144

  8. Lauren M Popov

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.

  9. Trevor J Parry

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.

  10. Dexter Pratt

    Department of Medicine, University of California, San Diego, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.

  11. Trey Ideker

    Department of Medicine, University of California, San Diego, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.

  12. Nevan J Krogan

    Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.

  13. Jeffery S Cox

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    For correspondence
    jeff.cox@berkeley.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5061-6618

Funding

National Institute of Allergy and Infectious Diseases (P01 AI063302)

  • Jeffery S Cox

Cystic Fibrosis Foundation (Harry Shwachman Award)

  • Jonathan M Budzik

National Institute of Allergy and Infectious Diseases (P01 AI063302)

  • Nevan J Krogan

National Institute of General Medical Sciences (P50 GM082250)

  • Nevan J Krogan

National Institute of Allergy and Infectious Diseases (U19 AI106754)

  • Nevan J Krogan

National Institute of Allergy and Infectious Diseases (U19 AI106754)

  • Jeffery S Cox

National Institute of Allergy and Infectious Diseases (DP1 AI124619)

  • Jeffery S Cox

National Institute of Allergy and Infectious Diseases (R01 AI120694)

  • Jeffery S Cox

National Institute of Allergy and Infectious Diseases (R01 AI120694)

  • Nevan J Krogan

National Institute of Allergy and Infectious Diseases (1K08AI146267)

  • Jonathan M Budzik

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: An animal use protocol (AUP-2015-11-8096) for mouse use was approved by the Office of Laboratory and Animal Care at the University of California, Berkeley, in adherence with guidelines from the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.

Copyright

© 2020, Budzik et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,778
    views
  • 825
    downloads
  • 53
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jonathan M Budzik
  2. Danielle L Swaney
  3. David Jimenez-Morales
  4. Jeffrey R Johnson
  5. Nicholas E Garelis
  6. Teresa Repasy
  7. Allison W Roberts
  8. Lauren M Popov
  9. Trevor J Parry
  10. Dexter Pratt
  11. Trey Ideker
  12. Nevan J Krogan
  13. Jeffery S Cox
(2020)
Dynamic post-translational modification profiling of M. tuberculosis-infected primary macrophages
eLife 9:e51461.
https://doi.org/10.7554/eLife.51461

Share this article

https://doi.org/10.7554/eLife.51461

Categories and tags

Further reading

    1. Microbiology and Infectious Disease

    Amidase and lysozyme dual functions in TseP reveal a new family of chimeric effectors in the type VI secretion system

    Zeng-Hang Wang, Ying An ... Tao Dong
    Research Article

    Peptidoglycan (PG) serves as an essential target for antimicrobial development. An overlooked reservoir of antimicrobials lies in the form of PG-hydrolyzing enzymes naturally produced for polymicrobial competition, particularly those associated with the type VI secretion system (T6SS). Here, we report that a T6SS effector TseP, from Aeromonas dhakensis, represents a family of effectors with dual amidase-lysozyme activities. In vitro PG-digestion coupled with LC-MS analysis revealed the N-domain’s amidase activity, which is neutralized by either catalytic mutations or the presence of the immunity protein TsiP. The N-domain, but not the C-domain, of TseP is sufficient to restore T6SS secretion in T6SS-defective mutants, underscoring its critical structural role. Using pull-down and secretion assays, we showed that these two domains interact directly with a carrier protein VgrG2 and can be secreted separately. Homologs in Aeromonas hydrophila and Pseudomonas syringae exhibited analogous dual functions. Additionally, N- and C-domains display distinctive GC contents, suggesting an evolutionary fusion event. By altering the surface charge through structural-guided design, we engineered the TsePC4+ effector that successfully lyses otherwise resistant Bacillus subtilis cells, enabling the T6SS to inhibit B. subtilis in a contact-independent manner. This research uncovers TseP as a new family of bifunctional chimeric effectors targeting PG, offering a potential strategy to harness these proteins in the fight against antimicrobial resistance.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease

    On the role of VP3-PI3P interaction in birnavirus endosomal membrane targeting

    Flavia A Zanetti, Ignacio Fernandez ... Laura Ruth Delgui
    Research Article

    Birnaviruses are a group of double-stranded RNA (dsRNA) viruses infecting birds, fish, and insects. Early endosomes (EE) constitute the platform for viral replication. Here, we study the mechanism of birnaviral targeting of EE membranes. Using the Infectious Bursal Disease Virus (IBDV) as a model, we validate that the viral protein 3 (VP3) binds to phosphatidylinositol-3-phosphate (PI3P) present in EE membranes. We identify the domain of VP3 involved in PI3P-binding, named P2 and localized in the core of VP3, and establish the critical role of the arginine at position 200 (R200), conserved among all known birnaviruses. Mutating R200 abolishes viral replication. Moreover, we propose a two-stage modular mechanism for VP3 association with EE. Firstly, the carboxy-terminal region of VP3 adsorbs on the membrane, and then the VP3 core reinforces the membrane engagement by specifically binding PI3P through its P2 domain, additionally promoting PI3P accumulation.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease

    Cellular Energy Production: Mycofactocin and the mycobacterial electron transport chain

    Stephanie M Stuteley, Ghader Bashiri
    Insight

    In the bacterium M. smegmatis, an enzyme called MftG allows the cofactor mycofactocin to transfer electrons released during ethanol metabolism to the electron transport chain.